Image

Early Detection of Myocardial Work Impairment in Obesity II(EARLY-MYO-OBESITY-II)

Early Detection of Myocardial Work Impairment in Obesity II(EARLY-MYO-OBESITY-II)

Recruiting
18-70 years
All
Phase N/A

Powered by AI

Overview

This prospective study intends to explore the change of cardiac structure and function in the cohort of overweight or obesity patients, and determine the impact of clinical characteristics on cardiac remodeling and mechanics.

Description

Obesity significantly increases the risk for heart failure. Early detection of preclinical cardiac dysfunction in overweight or obesity and understanding its association with insulin resistance are of great importance.Recently, a novel technique for myocardial work (MW) assessment has been introduced to evaluate myocardial performance. To date, change of MW has been described in several cardiac conditions including dilated cardiomyopathy, significant coronary arterial diseases, and hypertrophic cardiomyopathy, which implies regional or global myocardial dysfunction. In this study, we aimed to explore the alteration of MW in overweight or obese adults and to determine whether insulin resistance or other clinical risk factors may impact myocardial mechanics before impairment of systolic function.

Eligibility

Inclusion Criteria:

  • All patients were older than 18 without any cardiac symptoms.
  • The diagnosis of overweight was established when body mass index (BMI) of 25 to 30 kg/m2.
  • Obese was defined as a BMI of 30 kg/m2 or higher.

Exclusion Criteria:

  • diagnosis of type 2-Diabetes Mellitus according to the American Diabetes Association criteria;
  • left ventricular ejection fraction<50% on echocardiography;
  • arrythmia on electrocardiogram;
  • severe valvular stenosis or regurgitation;
  • history of coronary disease (defined as stenosis>50%) or myocardial infarction;
  • stress induced wall motion abnormality on echocardiography, coronary artery stenosis >50% on coronary CT or angiography with Framingham risk score of >10;
  • pacemaker or defibrillator implantation;
  • the presence of bundle branch block;
  • severe infection or renal dysfunction with an estimated glomerular filtration rate < 60 ml/min/1.73 m2);
  • inadequate image quality on echocardiography.

Study details
    Overweight and Obesity

NCT04933188

RenJi Hospital

21 March 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.